Massachusetts Institute of Technology v. Ab Fortia, Pharmacia Ab, Pharmacia Fine Chemicals Ab, Pharmacia, Inc. And U.S. International Trade Commission
Court of Appeals for the Federal Circuit
1Opinion of the Court
RICH, Circuit Judge.
This appeal is from the final decision of the United States International Trade Commission (Commission or ITC) in Certain Limited-Charge Cell Culture Microcarri-ers, Investigation No. 337-TA-129, an investigation under section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. § 1337 (section 337), determining that there was no violation of section 337 by the importation of certain biological cell culture products by respondents AB Fortia, Pharmacia AB, et al. We affirm.
Background
Cell culture technology is concerned with the development of the most efficient and safe or…
2Cases cited3 opinions
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- The Garrett Corporation v. The United StatesUnited States Court of Claims · 1970
- In re WyerCourt of Customs and Patent Appeals · 1981
3Cited by38 opinions
- Northern Telecom, Inc. v. Datapoint Corporation, Defendant/cross-AppellantCourt of Appeals for the Federal Circuit · 1990
- Typeright Keyboard Corporation v. Microsoft Corporation, Defendant-CrossCourt of Appeals for the Federal Circuit · 2004
- Cooper Cameron Corporation v. Kvaerner Oilfield Products, Inc., Defendant-Cross-AppellantCourt of Appeals for the Federal Circuit · 2002
- Astra Aktiebolag v. Andrx Pharmaceuticals, Inc.District Court, S.D. New York · 2002
- In Re Carol F. Klopfenstein and John L. Brent, JrCourt of Appeals for the Federal Circuit · 2004
33 more not listed; retrieve them via the Exa API.